| WKN: | A0MVJZ |
| ISIN: | FR0004056851 |
| Land: | Frankreich |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Valneva-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 25. Oktober 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 7,56 | 24,70 | 226,72% |
| 2 | 2020 | 2,51 | 7,56 | 201,20% |
| 3 | 2009 | 2,97 | 6,86 | 130,98% |
| 4 | 2025 | 2,13 | 4,03 | 89,20% |
| 5 | 2012 | 4,47 | 5,31 | 18,79% |
| 6 | 2018 | 2,75 | 2,99 | 8,73% |
| 7 | 2014 | 3,62 | 3,76 | 3,87% |
| 8 | 2015 | 3,76 | 3,80 | 1,06% |
| 9 | 2017 | 3,07 | 2,75 | -10,42% |
| 10 | 2010 | 6,86 | 5,89 | -14,14% |
| 11 | 2019 | 2,99 | 2,51 | -16,05% |
| 12 | 2016 | 3,80 | 3,07 | -19,21% |
| 13 | 2023 | 6,25 | 4,75 | -24,00% |
| 14 | 2011 | 5,89 | 4,47 | -24,11% |
| 15 | 2013 | 5,31 | 3,62 | -31,83% |
| 16 | 2008 | 4,62 | 2,97 | -35,71% |
| 17 | 2024 | 4,75 | 2,13 | -55,16% |
| 18 | 2022 | 24,70 | 6,25 | -74,70% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 24,70 | 6,25 | -74,70% |
| 2 | 2024 | 4,75 | 2,13 | -55,16% |
| 3 | 2008 | 4,62 | 2,97 | -35,71% |
| 4 | 2013 | 5,31 | 3,62 | -31,83% |
| 5 | 2011 | 5,89 | 4,47 | -24,11% |
| 6 | 2023 | 6,25 | 4,75 | -24,00% |
| 7 | 2016 | 3,80 | 3,07 | -19,21% |
| 8 | 2019 | 2,99 | 2,51 | -16,05% |
| 9 | 2010 | 6,86 | 5,89 | -14,14% |
| 10 | 2017 | 3,07 | 2,75 | -10,42% |
| 11 | 2015 | 3,76 | 3,80 | 1,06% |
| 12 | 2014 | 3,62 | 3,76 | 3,87% |
| 13 | 2018 | 2,75 | 2,99 | 8,73% |
| 14 | 2012 | 4,47 | 5,31 | 18,79% |
| 15 | 2025 | 2,13 | 4,03 | 89,20% |
| 16 | 2009 | 2,97 | 6,86 | 130,98% |
| 17 | 2020 | 2,51 | 7,56 | 201,20% |
| 18 | 2021 | 7,56 | 24,70 | 226,72% |